Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study)

Filetype[PDF-282.22 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Filetype[PDF - 572.74 KB]
      Personal Author:
      Belongia, Edward A.
      Corporate Authors:
      United States. Advisory Committee for Immunization Practices. Herpes Zoster Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/17/2017
      Series:
      ACIP meeting Herpes Zoster Vaccine
      Description:
      Presentations June 2017 Day 1Publication date from document properties.zoster-01-belongia.pdf
      File Type:
      Filetype[PDF - 572.74 KB]
      File Type:
      Filetype[PDF - 572.74 KB]
    2. Filetype[PDF - 1.62 MB]
      Personal Author:
      Dooling, Kathleen L.
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
      Published Date:
      7/17/2017
      Series:
      ACIP meeting Herpes Zoster Vaccine
      Description:
      Presentations June 2017 Day 1Publication date from document properties.zoster-05-dooling.pdf
      File Type:
      Filetype[PDF - 1.62 MB]
      File Type:
      Filetype[PDF - 1.62 MB]

You May Also Like:

  1. Filetype[PDF - 1.50 MB]
    Personal Author:
    Guo, Angela
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 October 25-26 : Atlanta, GA)
    Published Date:
    11/15/2017
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Presentations October 2017 Day 1Publication date from document properties.zoster-02-guo.pdf
    File Type:
    Filetype[PDF - 1.50 MB]
    File Type:
    Filetype[PDF - 1.50 MB]
  2. Filetype[PDF - 621.23 KB]
    Personal Author:
    Belongia, Edward A.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Zoster Working Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 June 24-25 : Atlanta, GA)
    Published Date:
    June 25, 2015
    Series:
    ACIP meeting Herpes Zoster Vaccine
    File Type:
    Filetype[PDF - 621.23 KB]
    File Type:
    Filetype[PDF - 621.23 KB]
  3. Filetype[PDF - 572.74 KB]
    Personal Author:
    Belongia, Edward A.
    Corporate Authors:
    United States. Advisory Committee for Immunization Practices. Herpes Zoster Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
    Published Date:
    7/17/2017
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Presentations June 2017 Day 1Publication date from document properties.zoster-01-belongia.pdf
    File Type:
    Filetype[PDF - 572.74 KB]
    File Type:
    Filetype[PDF - 572.74 KB]
  4. Filetype[PDF - 589.77 KB]
    Personal Author:
    Ortega-Sanchez, Ismael
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group. ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ;
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2013 October 23-24 : Atlanta, GA)
    Published Date:
    October 23, 2013
    Series:
    ACIP meeting Herpes Zoster Vaccine
    File Type:
    Filetype[PDF - 589.77 KB]
    File Type:
    Filetype[PDF - 589.77 KB]
  5. Filetype[PDF - 436.51 KB]
    Personal Author:
    Moore, Kelly L.
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Epidemiology and Prevention Branch. Influenza Surveillance and Outbreak Response Team.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    February 28, 2019
    Series:
    ACIP meeting Herpes Zoster Vaccine
    Description:
    Zoster-1-Moore-508.pdf
    File Type:
    Filetype[PDF - 436.51 KB]
    File Type:
    Filetype[PDF - 436.51 KB]